Spravato is the brand name for the esketamine based nasal spray. Esketamine is similar to ketamine, and Spravato was FDA-approved in 2019 for treatment-resistant major depression as well as suicidal ideation. Since Spravato has been FDA approved for over 5 years now, it’s common to wonder just how much the first legal psychedelic medicine costs. …
Depression affects millions of people worldwide—impacting over 20 million adults and adolescents in the United States alone. While many people respond to conventional mental health treatments, research shows that 10-30% of individuals with depression see little to no improvement. However, a ground-breaking new treatment called Spravato™ (esketamine) offers hope for those who haven’t found success …
Bespoke Treatment focuses on non-medication treatments that work. We are the first boutique center in Southern California to specialize in personalized TMS therapy, Ketamine treatment, and psychiatry.
